Tianda Pharmaceuticals Limited

SEHK:455 Stock Report

Market Cap: HK$397.8m

Tianda Pharmaceuticals Management

Management criteria checks 3/4

Tianda Pharmaceuticals' CEO is Alan Fang, appointed in Feb 2017, has a tenure of 7.83 years. directly owns 56.72% of the company’s shares, worth HK$225.62M. The average tenure of the management team and the board of directors is 7.8 years and 11.3 years respectively.

Key information

Alan Fang

Chief executive officer

HK$60.0k

Total compensation

CEO salary percentagen/a
CEO tenure7.8yrs
CEO ownership56.7%
Management average tenure7.8yrs
Board average tenure11.3yrs

Recent management updates

Recent updates

Is Tianda Pharmaceuticals (HKG:455) Weighed On By Its Debt Load?

Dec 10
Is Tianda Pharmaceuticals (HKG:455) Weighed On By Its Debt Load?

Lacklustre Performance Is Driving Tianda Pharmaceuticals Limited's (HKG:455) 25% Price Drop

Oct 28
Lacklustre Performance Is Driving Tianda Pharmaceuticals Limited's (HKG:455) 25% Price Drop

Tianda Pharmaceuticals Limited (HKG:455) Investors Are Less Pessimistic Than Expected

Aug 16
Tianda Pharmaceuticals Limited (HKG:455) Investors Are Less Pessimistic Than Expected

Is Tianda Pharmaceuticals (HKG:455) Using Debt In A Risky Way?

Jun 20
Is Tianda Pharmaceuticals (HKG:455) Using Debt In A Risky Way?

There's Reason For Concern Over Tianda Pharmaceuticals Limited's (HKG:455) Massive 26% Price Jump

Mar 27
There's Reason For Concern Over Tianda Pharmaceuticals Limited's (HKG:455) Massive 26% Price Jump

Estimating The Fair Value Of Tianda Pharmaceuticals Limited (HKG:455)

Mar 02
Estimating The Fair Value Of Tianda Pharmaceuticals Limited (HKG:455)

Is Tianda Pharmaceuticals (HKG:455) Using Debt Sensibly?

May 23
Is Tianda Pharmaceuticals (HKG:455) Using Debt Sensibly?

Tianda Pharmaceuticals (HKG:455) Has Debt But No Earnings; Should You Worry?

Dec 06
Tianda Pharmaceuticals (HKG:455) Has Debt But No Earnings; Should You Worry?

Does Tianda Pharmaceuticals (HKG:455) Have A Healthy Balance Sheet?

Jan 11
Does Tianda Pharmaceuticals (HKG:455) Have A Healthy Balance Sheet?

Does Tianda Pharmaceuticals (HKG:455) Have A Healthy Balance Sheet?

Aug 05
Does Tianda Pharmaceuticals (HKG:455) Have A Healthy Balance Sheet?

Is Tianda Pharmaceuticals (HKG:455) Using Too Much Debt?

Dec 11
Is Tianda Pharmaceuticals (HKG:455) Using Too Much Debt?

CEO

Alan Fang (55 yo)

7.8yrs

Tenure

HK$60,000

Compensation

Mr. Wen Quan Fang, also known as Alan, has been serves as Managing Director of Tianda Pharmaceuticals Limited since February 1, 2017. Mr. Fang has been Managing Director of Tianda Holdings Limited since Se...

Leadership Team

NamePositionTenureCompensationOwnership
Wen Quan Fang
Executive Chairman & MD7.8yrsHK$60.00k56.72%
HK$ 225.6m
Man Sang Lui
Executive Director11.3yrsHK$72.00kno data
Man Yuk Wong
Financial Controller4.9yrsno datano data
Tai On Lo
Company Secretaryno datano datano data

7.8yrs

Average Tenure

60yo

Average Age

Experienced Management: 455's management team is seasoned and experienced (7.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Wen Quan Fang
Executive Chairman & MD21.2yrsHK$60.00k56.72%
HK$ 225.6m
Man Sang Lui
Executive Director11.3yrsHK$72.00kno data
Sung Hong Chiu
Independent Non-Executive Director16.7yrsHK$72.00kno data
Yat-Fai Lam
Independent Non-Executive Director20.3yrsHK$72.00kno data
Tao Zhong
Non-Executive Director1.3yrsHK$25.00kno data
Quanming Feng
Non-Executive Director8.8yrsno datano data
Yanfang Xian
Independent Non-executive Director1.5yrsHK$37.00kno data

11.3yrs

Average Tenure

55yo

Average Age

Experienced Board: 455's board of directors are seasoned and experienced ( 11.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 18:32
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tianda Pharmaceuticals Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jayaprabha DhavaleVirtua Research Inc.